Basit öğe kaydını göster

dc.contributor.authorHatemi, G
dc.contributor.authorMandel, NM
dc.contributor.authorYucel, A
dc.contributor.authorDe Hoog, GS
dc.contributor.authorKantarcioglu, AS
dc.date.accessioned2021-03-02T21:50:40Z
dc.date.available2021-03-02T21:50:40Z
dc.identifier.citationKantarcioglu A., Hatemi G., Yucel A., De Hoog G., Mandel N., "Paecilomyces variotii central nervous system infection in a patient with cancer", MYCOSES, cilt.46, ss.45-50, 2003
dc.identifier.issn0933-7407
dc.identifier.othervv_1032021
dc.identifier.otherav_093640bf-1bbf-4b36-9ffc-8d331616d2f0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/12005
dc.identifier.urihttps://doi.org/10.1046/j.1439-0507.2003.00837.x
dc.description.abstractPaecilomyces variotii was isolated from two subsequent cerebrospinal fluid (CSF) specimens of a cancer patient. Identification was confirmed through beta-tubulin and rDNA ITS sequencing. MICs were determined for seven antifungal agents; the isolate was found to be susceptible to amphotericin B (AMB), itraconazole (ITZ), ketaconazole (KTZ) and 5-fluorocytosine (5FC) but resistant to fluconazole (FLZ) and miconazole (MCZ). Despite antimycotic therapy, the infection proved to be fatal.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectDermatoloji
dc.subjectTarımsal Bilimler
dc.subjectZiraat
dc.subjectBitki Koruma
dc.subjectFitopatoloji
dc.subjectMikoloji
dc.subjectTarım ve Çevre Bilimleri (AGE)
dc.subjectTıp
dc.subjectBitki ve Hayvan Bilimleri
dc.subjectMİKOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectDERMATOLOJİ
dc.titlePaecilomyces variotii central nervous system infection in a patient with cancer
dc.typeMakale
dc.relation.journalMYCOSES
dc.contributor.department, ,
dc.identifier.volume46
dc.identifier.startpage45
dc.identifier.endpage50
dc.contributor.firstauthorID167570


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster